Salbutamol
- Generic Name
- Salbutamol
- Brand Names
- Airomir, Airsupra, Combivent, Proair, Proventil, Ventolin
- Drug Type
- Small Molecule
- Chemical Formula
- C13H21NO3
- CAS Number
- 18559-94-9
- Unique Ingredient Identifier
- QF8SVZ843E
- Background
Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and...
- Indication
Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known t...
- Associated Conditions
- Asthma, Asthmatic Bronchitis, Bronchial Asthma, Bronchoconstriction, Bronchospasm, Chronic Asthma, Chronic Bronchitis, Cough, Emphysema, Exacerbation of asthma, Exercise-Induced Bronchospasm, Hyperkalemia, Wheezing, Excess mucus or phlegm
- Associated Therapies
- Airway secretion clearance therapy, Bronchodilation
Effect of Nebulized Bronchodilators on Heart Rate
- First Posted Date
- 2010-06-28
- Last Posted Date
- 2015-10-23
- Lead Sponsor
- Fahim Khorfan, MD
- Target Recruit Count
- 89
- Registration Number
- NCT01151579
- Locations
- 🇺🇸
Genesys Regional Medical Center, Grand Blanc, Michigan, United States
Characterization of Placebo Responses in Stable Asthma
- Conditions
- Interventions
- First Posted Date
- 2010-06-14
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT01143688
- Locations
- 🇺🇸
Brigham & women's Hospital, Boston, Massachusetts, United States
Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2010-03-24
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 96
- Registration Number
- NCT01091337
- Locations
- 🇵🇭
Philippine General Hospital, Manila, Philippines
Bronchodilator Responsiveness in Healthy Young Adults Using Forced Oscillations Technique (FOT)
- Conditions
- First Posted Date
- 2010-02-11
- Last Posted Date
- 2011-01-19
- Lead Sponsor
- University of Patras
- Target Recruit Count
- 100
- Registration Number
- NCT01067534
- Locations
- 🇬🇷
University Hospital of Patras, Patras, Greece
Dose-response of Albuterol in Asthmatics
- Conditions
- First Posted Date
- 2009-07-17
- Last Posted Date
- 2015-05-05
- Lead Sponsor
- Nemours Children's Clinic
- Target Recruit Count
- 81
- Registration Number
- NCT00940927
- Locations
- 🇺🇸
Nemours Children's Clinic, Jacksonville, Florida, United States
Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients
- First Posted Date
- 2009-06-02
- Last Posted Date
- 2009-06-02
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 6
- Registration Number
- NCT00911651
- Locations
- 🇧🇪
Antwerp University Hospital, Antwerp, Belgium
Rapid Onset Action of Salbutamol Versus Formoterol
- First Posted Date
- 2009-05-13
- Last Posted Date
- 2009-05-13
- Target Recruit Count
- 78
- Registration Number
- NCT00900874
- Locations
- 🇮🇳
AIIMS, New Delhi, India
Role of Airway Hyperresponsiveness on Performance in Elite Swimmers.
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Laval University
- Target Recruit Count
- 57
- Registration Number
- NCT00876135
- Locations
- 🇨🇦
Institut Universitaire de cardiologie et de pneumologie de Québec, Québec, Quebec, Canada
Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics
- First Posted Date
- 2009-03-16
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 2079
- Registration Number
- NCT00861926
- Locations
- 🇮🇹
Pr Papi, Ferrara, Italy
Symbicort Onset of Action 2
- Conditions
- Interventions
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 48
- Registration Number
- NCT00646009
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.